Development code · Small Molecule
TLL-041
TLL-041 is a development code for BHV-8000, developed by Biohaven Ltd..
- Status
- Phase 2/3 for Parkinson's disease
- Mechanism
- TYK2 Inhibitor
- Developer
- Biohaven Ltd.
Programs
- BHV-8000 for Parkinson's diseasePhase 2/3Recruiting
Also known as
- BHV-8000